CaM Kinase II mediates maladaptive post-infarct remodeling and pro-inflammatory chemoattractant signaling but not acute myocardial ischemia/reperfusion injury

EMBO Molecular Medicine

Volumn 6, Issue 10, 2014, Pages 1231-1245

  Weinreuter, Martin ^a,b   Kreusser, Michael M ^a,b   Beckendorf, Jan ^a,b   Schreiter, Friederike C ^a,b   Leuschner, Florian ^a,b   Lehmann, Lorenz H ^a,b   Hofmann, Kai P ^a,b   Rostosky, Julia S ^a,b   Diemert, Nathalie ^a,b   Xu, Chang ^a,b   Volz, Hans Christian ^a,b   Jungmann, Andreas ^a,b   Nickel, Alexander ^c   Sticht, Carsten ^a   Gretz, Norbert ^a   Maack, Christoph ^c   Schneider, Michael D ^d   Gröne, Hermann Josef ^e   Müller, Oliver J ^a,b   Katus, Hugo A ^a,b   Backs, Johannes ^a,b   more..

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; Ca2+ calmodulin dependent protein kinase II; Cardiac remodeling; Gene replacement; Ischemia reperfusion injury

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CHEMOATTRACTANT; ENALAPRIL; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; AUTACOID; CHEMOKINE; CHEMOTACTIC FACTOR; ISOENZYME;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; FOLLOW UP; GENETIC MODEL; HEART INJURY; HEART MUSCLE CELL; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVASCULARIZATION; SCAR FORMATION; UPREGULATION; ADAPTATION; ANIMAL; GENE EXPRESSION; GENETICS; HEART; HEART INFARCTION; IMMUNOLOGY; LEUKOCYTE; METABOLISM; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; PATHOPHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BLOTTING, WESTERN; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CHEMOKINE CCL3; CHEMOKINES; CHEMOTACTIC FACTORS; GENE EXPRESSION; HEART; INFLAMMATION MEDIATORS; ISOENZYMES; LEUKOCYTES; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84908103688     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.15252/emmm.201403848     Document Type: Article

References (64)

1. Agah R, Frenkel PA, French BA, Michael LH, Overbeek PA, Schneider MD (1997) Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J Clin Invest 100: 169-179
2. Alves GD, Pazzine M, Gomes de Macedo Braga LM, Irigoyen MC, De Angelis K, Ikuta N, Camassola M, Nardi NB (2012) Molecular mapping of the regenerative niche in a murine model of myocardial infarction. Int J Mol Med 29: 479-484
3. Anderson ME, Brown JH, Bers DM (2011) CaMKII in myocardial hypertrophy and heart failure. J Mol Cell Cardiol 51: 468-473
4. Backs J, Song K, Bezprozvannaya S, Chang S, Olson EN (2006) CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J Clin Invest 116: 1853-1864
5. Backs J, Backs T, Bezprozvannaya S, McKinsey TA, Olson EN (2008) Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4. Mol Cell Biol 28: 3437-3445
6. Backs J, Backs T, Neef S, Kreusser MM, Lehmann LH, Patrick DM, Grueter CE, Qi X, Richardson JA, Hill JA et al (2009) The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc Natl Acad Sci USA 106: 2342-2347
7. Backs J, Stein P, Backs T, Duncan FE, Grueter CE, McAnally J, Qi X, Schultz RM, Olson EN (2010) The gamma isoform of CaM kinase II controls mouse egg activation by regulating cell cycle resumption. Proc Natl Acad Sci USA 107: 81-86
8. Birdsall HH, Green DM, Trial J, Youker KA, Burns AR, MacKay CR, LaRosa GJ, Hawkins HK, Smith CW, Michael LH et al (1997) Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion. Circulation 95: 684-692
9. Braun AP, Schulman H (1995) The multifunctional calcium/calmodulin-dependent protein kinase: from form to function. Annu Rev Physiol 57: 417-445
10. Clark RI, Tan SW, Pean CB, Roostalu U, Vivancos V, Bronda K, Pilatova M, Fu J, Walker DW, Berdeaux R et al (2013) MEF2 is an in vivo immune-metabolic switch. Cell 155: 435-447
11. 2+/calmodulin-dependent protein kinase II in vivo. Mol Endocrinol 17: 183-192
12. Correll RN, Molkentin JD (2013) CaMKII does it again: even the mitochondria cannot escape its influence. Circ Res 112: 1208-1211
13. 2+ oscillations. Science 279: 227-230
14. Erickson JR, Joiner ML, Guan X, Kutschke W, Yang J, Oddis CV, Bartlett RK, Lowe JS, O'Donnell SE, Aykin-Burns N et al (2008) A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 133: 462-474
15. Ertl G, Frantz S (2005) Healing after myocardial infarction. Cardiovasc Res 66: 22-32
16. Frangogiannis NG (2008) The immune system and cardiac repair. Pharmacol Res 58: 88-111
17. Gao L, Blair LA, Marshall J (2006) CaMKII-independent effects of KN93 and its inactive analog KN92: reversible inhibition of L-type calcium channels. Biochem Biophys Res Commun 345: 1606-1610
18. Geisler A, Jungmann A, Kurreck J, Poller W, Katus HA, Vetter R, Fechner H, Muller OJ (2011) microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors. Gene Ther 18: 199-209
19. Ginnan R, Sun LY, Schwarz JJ, Singer HA (2012) MEF2 is regulated by CaMKIIdelta2 and a HDAC4-HDAC5 heterodimer in vascular smooth muscle cells. Biochem J 444: 105-114
20. Goehringer C, Rutschow D, Bauer R, Schinkel S, Weichenhan D, Bekeredjian R, Straub V, Kleinschmidt JA, Katus HA, Muller OJ (2009) Prevention of cardiomyopathy in delta-sarcoglycan knockout mice after systemic transfer of targeted adeno-associated viral vectors. Cardiovasc Res 82: 404-410
21. Goser S, Ottl R, Brodner A, Dengler TJ, Torzewski J, Egashira K, Rose NR, Katus HA, Kaya Z (2005) Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy. Circulation 112: 3400-3407
22. He BJ, Joiner ML, Singh MV, Luczak ED, Swaminathan PD, Koval OM, Kutschke W, Allamargot C, Yang J, Guan X et al (2011) Oxidation of CaMKII determines the cardiotoxic effects of aldosterone. Nat Med 17: 1610-1618
23. 2+/calmodulin-dependent protein kinase II. Biochem J 364: 593-611
24. James TN (1998) The variable morphological coexistence of apoptosis and necrosis in human myocardial infarction: significance for understanding its pathogenesis, clinical course, diagnosis and prognosis. Coron Artery Dis 9: 291-307
25. Joiner ML, Koval OM, Li J, He BJ, Allamargot C, Gao Z, Luczak ED, Hall DD, Fink BD, Chen B et al (2012) CaMKII determines mitochondrial stress responses in heart. Nature 491: 269-273
26. Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler W (1991) Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 67: 1360-1367
27. Kehat I, Molkentin JD (2010) Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation 122: 2727-2735
28. Kim Y, Phan D, van Rooij E, Wang DZ, McAnally J, Qi X, Richardson JA, Hill JA, Bassel-Duby R, Olson EN (2008) The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. J Clin Invest 118: 124-132
29. Koitabashi N, Bedja D, Zaiman AL, Pinto YM, Zhang M, Gabrielson KL, Takimoto E, Kass DA (2009) Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models. Circ Res 105: 12-15
30. Kreusser MM, Backs J (2014) Integrated mechanisms of CaMKII-dependent ventricular remodeling. Front Pharmacol 5: 36
31. Lehmann LH, Worst BC, Stanmore DA, Backs J (2014) Histone deacetylase signaling in cardioprotection. Cell Mol Life Sci 71: 1673-1690
32. Leuschner F, Panizzi P, Chico-Calero I, Lee WW, Ueno T, Cortez-Retamozo V, Waterman P, Gorbatov R, Marinelli B, Iwamoto Y et al (2010) Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ Res 107: 1364-1373
33. Leuschner F, Rauch PJ, Ueno T, Gorbatov R, Marinelli B, Lee WW, Dutta P, Wei Y, Robbins C, Iwamoto Y et al (2012) Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med 209: 123-137
34. 2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. J Clin Invest 119: 1230-1240
35. 2+/calmodulin-dependent protein kinase II delta mediates myocardial ischemia/reperfusion injury through nuclear factor-kappaB. Circ Res 112: 935-944
36. Little GH, Saw A, Bai Y, Dow J, Marjoram P, Simkhovich B, Leeka J, Kedes L, Kloner RA, Poizat C (2009) Critical role of nuclear calcium/calmodulin-dependent protein kinase IIdeltaB in cardiomyocyte survival in cardiomyopathy. J Biol Chem 284: 24857-24868
37. Machado FS, Souto JT, Rossi MA, Esper L, Tanowitz HB, Aliberti J, Silva JS (2008) Nitric oxide synthase-2 modulates chemokine production by trypanosoma cruzi-infected cardiac myocytes. Microbes Infect 10: 1558-1566
38. 2+ release. Circ Res 92: 904-911
39. 2+/calmodulin kinase II after beta(1)-adrenergic receptor stimulation. J Cell Biol 189: 573-587
40. McCully JD, Wakiyama H, Hsieh YJ, Jones M, Levitsky S (2004) Differential contribution of necrosis and apoptosis in myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 286: H1923-H1935
41. Means AR (2000) Regulatory cascades involving calmodulin-dependent protein kinases. Mol Endocrinol 14: 4-13
42. Mishra S, Gray CB, Miyamoto S, Bers DM, Brown JH (2011) Location matters: clarifying the concept of nuclear and cytosolic CaMKII subtypes. Circ Res 109: 1354-1362
43. Molkentin JD, Robbins J (2009) With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure. J Mol Cell Cardiol 46: 130-136
44. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, Libby P, Weissleder R, Pittet MJ (2007) The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 204: 3037-3047
45. Peng W, Zhang Y, Zheng M, Cheng H, Zhu W, Cao CM, Xiao RP (2010) Cardioprotection by CaMKII-deltaB is mediated by phosphorylation of heat shock factor 1 and subsequent expression of inducible heat shock protein 70. Circ Res 106: 102-110
46. Pfeffer MA, Braunwald E (1990) Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81: 1161-1172
47. Rezazadeh S, Claydon TW, Fedida D (2006) KN-93 (2-[N-(2-hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N -methylbenzylamine), a calcium/calmodulin-dependent protein kinase II inhibitor, is a direct extracellular blocker of voltage-gated potassium channels. J Pharmacol Exp Ther 317: 292-299
48. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM (1997) Apoptosis in human acute myocardial infarction. Circulation 95: 320-323
49. Schinkel S, Bauer R, Bekeredjian R, Stucka R, Rutschow D, Lochmuller H, Kleinschmidt JA, Katus HA, Muller OJ (2012) Long-term preservation of cardiac structure and function after adeno-associated virus serotype 9-mediated microdystrophin gene transfer in mdx mice. Hum Gene Ther 23: 566-575
50. +) current. Basic Res Cardiol 106: 263-272
51. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550
52. Timmins JM, Ozcan L, Seimon TA, Li G, Malagelada C, Backs J, Backs T, Bassel-Duby R, Olson EN, Anderson ME et al (2009) Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways. J Clin Invest 119: 2925-2941
53. 2+/CaM-dependent protein kinase genes. Gene 322: 17-31
54. Vila-Petroff M, Salas MA, Said M, Valverde CA, Sapia L, Portiansky E, Hajjar RJ, Kranias EG, Mundina-Weilenmann C, Mattiazzi A (2007) CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury. Cardiovasc Res 73: 689-698
55. Yang Y, Zhu WZ, Joiner ML, Zhang R, Oddis CV, Hou Y, Yang J, Price EE, Gleaves L, Eren M et al (2006) Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo. Am J Physiol Heart Circ Physiol 291: H3065-H3075
56. Yoo B, Lemaire A, Mangmool S, Wolf MJ, Curcio A, Mao L, Rockman HA (2009) Beta1-adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction. Am J Physiol Heart Circ Physiol 297: H1377-H1386
57. Zhang X, Azhar G, Chai J, Sheridan P, Nagano K, Brown T, Yang J, Khrapko K, Borras AM, Lawitts J et al (2001) Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Am J Physiol Heart Circ Physiol 280: H1782-H1792
58. 2+/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity. J Biol Chem 277: 1261-1267
59. Zhang T, Maier LS, Dalton ND, Miyamoto S, Ross J Jr, Bers DM, Brown JH (2003) The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ Res 92: 912-919
60. Zhang R, Khoo MS, Wu Y, Yang Y, Grueter CE, Ni G, Price EE Jr, Thiel W, Guatimosim S, Song LS et al (2005) Calmodulin kinase II inhibition protects against structural heart disease. Nat Med 11: 409-417
61. Zhang T, Kohlhaas M, Backs J, Mishra S, Phillips W, Dybkova N, Chang S, Ling H, Bers DM, Maier LS et al (2007) CaMKIIdelta isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses. J Biol Chem 282: 35078-35087
62. 2+ handling but exacerbates cardiac dysfunction in CaMKIIdelta(C) transgenic mice. Circ Res 106: 354-362
63. 2+/calmodulin kinase II. J Clin Invest 111: 617-625
64. Zhu W, Woo AY, Yang D, Cheng H, Crow MT, Xiao RP (2007) Activation of CaMKIIdeltaC is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis. J Biol Chem 282: 10833-10839